Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
100 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01866839 | Preventing Stem Cell Transplant Complications With a Blood Separator Machine | completed | Phase 1 / Phase 2 | 41 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 21, 2020 | clinicaltrials |
| NCT01117142 | A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers | completed | — | 20 | National Heart, Lung, and Blood Institute (NHLBI) |
| 1 |
| Jul 14, 2020 |
| clinicaltrials |
| NCT00003553 | Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 156 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jun 19, 2020 | clinicaltrials |
| NCT02322320 | Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT) | completed | Phase 3 | 273 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | May 11, 2020 | clinicaltrials |
| NCT00001637 | Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults | completed | Phase 2 | 28 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00001872 | Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease | completed | — | 14 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01629082 | Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia | completed | Phase 1 | 4 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT02231853 | Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections | terminated | Phase 1 | 12 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00353860 | Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances | completed | Phase 2 | 70 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00001623 | Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia | completed | N/A | 41 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT00353821 | Investigating Cytokine Genes of Stem Cell Donors | completed | — | 24 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT00861510 | A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies | completed | Phase 1 | 16 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 3, 2019 | clinicaltrials |
| NCT01419574 | Ultrasound and Other Images of Artery Blockages | terminated | — | 12 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 3, 2019 | clinicaltrials |
| NCT02527447 | Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15) | completed | — | 15 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Oct 30, 2019 | clinicaltrials |
| NCT00552955 | Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women | completed | — | 35 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 6, 2019 | clinicaltrials |
| NCT02208037 | Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) | completed | Phase 2 | 279 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jan 23, 2019 | clinicaltrials |
| NCT00001873 | The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers | completed | Phase 2 | 102 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Sep 26, 2018 | clinicaltrials |
| NCT00061581 | Experimental Bone Marrow Transplant Protocol | completed | Phase 2 | 14 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Sep 26, 2018 | clinicaltrials |
| NCT00467961 | Stem Cell Transplantation for Patients With Cancers of the Blood | completed | Phase 2 | 61 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 13, 2018 | clinicaltrials |
| NCT01517035 | Improving Blood Stem Cell Collection and Transplant Procedures | completed | Phase 1 / Phase 2 | 43 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT02226861 | Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation | completed | Phase 1 | 24 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT00001893 | Study of TNFR:Fc (Enbrel) in the Treatment of Asthma | completed | Phase 2 | 150 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00006413 | Stem Cell Transplantation to Treat Systemic Mastocytosis | completed | Phase 2 | 25 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00079313 | Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia | completed | Phase 2 | 7 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00270452 | Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome | completed | Phase 1 | 9 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00366418 | Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia | completed | Phase 1 | 4 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00819143 | Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease | completed | — | 3 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01322165 | National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions(GenTAC) | completed | — | 3,706 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 20, 2016 | clinicaltrials |
| NCT00000589 | Trial to Reduce Alloimmunization to Platelets (TRAP) | completed | Phase 3 | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Nov 7, 2016 | clinicaltrials |
| NCT00025662 | Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS | completed | Phase 2 | 23 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Oct 28, 2016 | clinicaltrials |
| NCT00005459 | Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome | completed | — | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Jul 29, 2016 | clinicaltrials |
| NCT00000591 | T-Cell Depletion in Unrelated Donor Marrow Transplantation | completed | Phase 3 | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Apr 15, 2016 | clinicaltrials |
| NCT00000611 | Women's Health Initiative (WHI) | completed | Phase 3 | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Apr 15, 2016 | clinicaltrials |
| NCT00000603 | Cord Blood Stem Cell Transplantation Study (COBLT) | completed | Phase 2 | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Apr 14, 2016 | clinicaltrials |
| NCT00005418 | Epidemiology of Cardiotoxicity in Children With Cancer | completed | — | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Mar 16, 2016 | clinicaltrials |
| NCT00005494 | Prospective Study of Health in Runners and Walkers | completed | — | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Feb 29, 2016 | clinicaltrials |
| NCT00005486 | Lymphangioleiomyomatosis (LAM) Registry | completed | — | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Feb 18, 2016 | clinicaltrials |
| NCT00023530 | Blood and Marrow Transplant Clinical Research Network | completed | N/A | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Feb 18, 2016 | clinicaltrials |
| NCT00079391 | Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies | completed | Phase 2 | 50 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Oct 26, 2015 | clinicaltrials |
| NCT00006240 | Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia | completed | Phase 2 | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00433745 | Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy | completed | Phase 2 | 4 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00066417 | Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia | terminated | Phase 2 | 51 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | May 1, 2013 | clinicaltrials |
| NCT00005906 | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | completed | Phase 2 | 4 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00001144 | Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia | completed | Phase 2 | 50 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Oct 7, 2008 | clinicaltrials |
| NCT00001229 | Diagnosis and Treatment of Pheochromocytoma | completed | — | 240 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001748 | HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies | completed | Phase 1 | 35 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001750 | Comparing Treatments for Multiple Myeloma | completed | Phase 2 | 32 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001869 | Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM) | completed | — | 400 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001877 | Treatment of Pulmonary Sarcoidosis With Pentoxifylline | completed | Phase 2 | 100 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001533 | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | completed | Phase 1 | 25 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 17, 2006 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials